Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-29T17:35:06.844Z Has data issue: false hasContentIssue false

Pain in depression

Published online by Cambridge University Press:  16 April 2020

N. Dantchev
Affiliation:
Hotel-Dieu, Paris, France
M. Bauer
Affiliation:
Charite-University Medicine Berlin, Berlin, Germany
K. Demyttenaere
Affiliation:
Universitair Aiekenhuis Gasthuisberg, Leuven, Belgium
A. Garcia-Cebrian
Affiliation:
Eli Lilly and Company Limited, Windlesham, United Kingdom
L. Grassi
Affiliation:
University of Ferrara, Ferrara, Italy
A.L. Montejo
Affiliation:
Hospital Universitario de Salamanca, Salamanca, Spain
B. Monz
Affiliation:
Boehringer Ingelheim International, Ingelheim, Germany
D. Perahia
Affiliation:
Eli Lilly and Company Limited, Windlesham, United Kingdom The Gordon Hospital, London, United Kingdom
D. Quail
Affiliation:
Eli Lilly and Company Limited, Windlesham, United Kingdom
C. Reed
Affiliation:
Eli Lilly and Company Limited, Windlesham, United Kingdom
A. Tylee
Affiliation:
Institute of Psychiatry, London, United Kingdom

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The objective is to describe the prevalence and nature of painful symptoms among depressive outpatients and how are they related with depressive symptoms and somatic non painful symptoms at baseline.

Methods

The FINDER study, conducted in 12 European countries in depressed outpatients in routine primary and specialist care settings provides a unique opportunity to answer these questions.

Painful symptoms were evaluated among 3468 patients enrolled by 437 investigators, using the 28-item Somatic Symptom Inventory (SSI-28) and 6 Visual Analogue Scales (1 item on overall pain and 5 items on pain characteristics: headaches, back pain, shoulder pain, interferences with daily activities and pain while awake). There was a strong correlation between the VAS overall pain score and the pain sub score of the SSI-28. The threshold score of 30 mm on the overall pain severity in combination with selected comorbidities was used to divide patients in three pain cohorts: (1) those with no/mild pain; (2) those with moderate/severe œmedically explained pain and (3) those with moderate/severe medically unexplained pain.

Results

Results showed that 1447 (43.7%) patients had no/mild pain, 550 (16,6%) had moderate/severe medically explained pain, and 1311 (39,6%) had moderate/severe medically unexplained pain. Of the different locations of pain symptoms (from the SSI-28), headaches were the most common, followed by muscle soreness and lower back pain. The mean depression score (HADS-D) was higher in patients with pain-related symptoms.

Conclusion

We studied the correlations between the measures of pain and depression. These results and their implications will be discussed.

Type
S32. Symposium: Factors Influencing Depression Endpoints Research (Finder)–Aeuropean Study
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.